Are Participants in Pharmacological and Psychotherapy Treatment Trials for Social Anxiety Disorder Representative of Patients in Real-Life Settings?
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The present study sought to quantify the generalizability of clinical trial results in individuals with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, diagnosis of social anxiety disorder (SAD) to a large representative community sample. METHODS: Data were derived from the 2004-2005 National Epidemiologic Survey on Alcohol and Related Conditions, a large nationally representative sample of 34,653 adults from the US population. We applied a standard set of exclusion criteria representative of pharmacological and psychotherapy clinical trials to all adults with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, diagnosis of SAD (n = 965) in the past 12 months and then to a subsample of participants seeking treatment (n = 363). Our aim was to assess how many participants with SAD would fulfill typical eligibility criteria. RESULTS: We found that more than 7 of 10 respondents from the overall SAD sample in a typical pharmacological efficacy trial and more than 6 of 10 participants in a typical psychotherapy efficacy trial would have been excluded by at least 1 criterion. In addition, more than 8 of 10 respondents seeking treatment for SAD would have been excluded from participation in a typical pharmacological or psychotherapy efficacy trial. Having a current major depression explained a large proportion of ineligibility. CONCLUSIONS: Clinical trials should carefully consider the impact of exclusion criteria on the generalizability of their results and explain the rationale for their use. For SAD treatment trials to adequately inform clinical practice, the eligibility rate must be increased through a general relaxation of overly stringent eligibility criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661
Cohen, P. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790230064010 · Cited by 607 · cited 1×
“Paradoxically, clinical trials may tend to exclude preferentially individuals who have the greatest overall disease severity and, therefore, the greatest need for treatment.(92) We would make some cautionary notes about our study.”
BackgroundClark, D. M., Ehlers, A., Hackmann, A., McManus, F., Fennell, M., Grey, N., Waddington, L., & Wild, J. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.3.568 · Cited by 603
Grant, B. F., Hasin, D. S., Blanco, C., Stinson, F. S., Chou, S. P., Goldstein, R. B., Dawson, D. A., Smith, S., Saha, T. D., & Huang, B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1102 · Cited by 601
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., Juster, H. R., Campeas, R., Bruch, M. A., Cloitre, M., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1133 · Cited by 585
Grant, B. F., Stinson, F. S., Hasin, D. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Huang, B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1001 · Cited by 479 · cited 1×
“The wave 2 NESARC data were weighted to reflect design characteristics of the NESARC survey and to account for oversampling.(36) The research protocol, including written informed consent procedures, received full human subjects review and approval from the US Census Bureau and the Office of Management and Budget.”
MethodAndersson, G., Carlbring, P., Holmström, A., Sparthan, E., Furmark, T., Nilsson-Ihrfelt, E., Buhrman, M., & Ekselius, L. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.677 · Cited by 382
Cognitive mediation of treatment change in social phobia
Hofmann, S. G. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.3.392 · Cited by 348
Psychological treatment of social anxiety disorder: a meta-analysis
Acarturk, C., Cuijpers, P., van Straten, A., & de Graaf, R. (2009) · Psychological Medicine · doi:10.1017/s0033291708003590 · Cited by 333
Cited by
Hasin, D. S., & Grant, B. F. (2015) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-015-1088-0 · Cited by 452
Lorenzo-Luaces, L., Johns, E., & Keefe, J. R. (2018) · Journal of Medical Internet Research · doi:10.2196/10113 · Cited by 36
Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder
Blanco, C., Hoertel, N., Franco, S., Olfson, M., He, J.-P., López, S., González-Pinto, A., Limosin, F., & Merikangas, K. R. (2017) · Pediatrics · doi:10.1542/peds.2016-1701 · Cited by 29
Self-citationPeyre, H., Hoertel, N., Rivollier, F., Landman, B., McMahon, K., Chevance, A., Lemogne, C., Delorme, R., Blanco, C., & Limosin, F. (2016) · Depression and Anxiety · doi:10.1002/da.22547 · Cited by 24
“…SAD, social anxiety disorder; SE, standard error ing major depressive disorder and substance use disorders (Blanco et al., 2011; Grant et al., 2005; Hoertel et al., 2014; Magee, Eaton, Wittchen, McGonagle, & Kessler, 1996; Schneier et al., 2010; Stein, Torgrud, & Walker, 2000) and constitute a…”
BackgroundMethodSelf-citationRozen, N., & Aderka, I. M. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101874 · Cited by 5
Metadata
- Authors
- Hoertel, N., de Maricourt, P., Katz, J., Doukhan, R., Lavaud, P., Peyre, H., & Limosin, F.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2014-12
- Volume
- 34
- Issue
- 6
- Pages
- 697-703
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2323725091
- Cited by
- 27
- References
- 24
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are Participants in Pharmacological and Psychotherapy Treatment Trials for Social Anxiety Disorder Representative of Patients in Real-Life Settings? https://app.cochat.ai/papers/10.1097/jcp.0000000000000204
- The paper
- Hoertel, N., de Maricourt, P., Katz, J., Doukhan, R., Lavaud, P., Peyre, H., & Limosin, F. (2014). Are Participants in Pharmacological and Psychotherapy Treatment Trials for Social Anxiety Disorder Representative of Patients in Real-Life Settings? Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000204
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.